Cargando…
Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment
Resveratrol possesses several beneficial metabolic effects in rodents, while the effects of resveratrol in humans remain unclear. Therefore, we performed a non-targeted comprehensive metabolomic analysis on blood, urine, adipose tissue, and skeletal muscle tissue in middle-aged men with metabolic sy...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372570/ https://www.ncbi.nlm.nih.gov/pubmed/28273841 http://dx.doi.org/10.3390/ijms18030554 |
_version_ | 1782518645846441984 |
---|---|
author | Korsholm, Anne Sofie Kjær, Thomas Nordstrøm Ornstrup, Marie Juul Pedersen, Steen Bønløkke |
author_facet | Korsholm, Anne Sofie Kjær, Thomas Nordstrøm Ornstrup, Marie Juul Pedersen, Steen Bønløkke |
author_sort | Korsholm, Anne Sofie |
collection | PubMed |
description | Resveratrol possesses several beneficial metabolic effects in rodents, while the effects of resveratrol in humans remain unclear. Therefore, we performed a non-targeted comprehensive metabolomic analysis on blood, urine, adipose tissue, and skeletal muscle tissue in middle-aged men with metabolic syndrome randomized to either resveratrol or placebo treatment for four months. Changes in steroid hormones across all four matrices were the most pronounced changes observed. Resveratrol treatment reduced sulfated androgen precursors in blood, adipose tissue, and muscle tissue, and increased these metabolites in urine. Furthermore, markers of muscle turnover were increased and lipid metabolism was affected, with increased intracellular glycerol and accumulation of long-chain saturated, monounsaturated, and polyunsaturated (n3 and n6) free fatty acids in resveratrol-treated men. Finally, urinary derivatives of aromatic amino acids, which mainly reflect the composition of the gut microbiota, were altered upon resveratrol treatment. In conclusion, the non-targeted metabolomics approach applied to four different matrices provided evidence of subtle but robust effects on several metabolic pathways following resveratrol treatment for four months in men with metabolic syndrome—effects that, for the most part, would not have been detected by routine analyses. The affected pathways should be the focus of future clinical trials on resveratrol’s effects, and perhaps particularly the areas of steroid metabolism and the gut microbiome. |
format | Online Article Text |
id | pubmed-5372570 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-53725702017-04-10 Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment Korsholm, Anne Sofie Kjær, Thomas Nordstrøm Ornstrup, Marie Juul Pedersen, Steen Bønløkke Int J Mol Sci Article Resveratrol possesses several beneficial metabolic effects in rodents, while the effects of resveratrol in humans remain unclear. Therefore, we performed a non-targeted comprehensive metabolomic analysis on blood, urine, adipose tissue, and skeletal muscle tissue in middle-aged men with metabolic syndrome randomized to either resveratrol or placebo treatment for four months. Changes in steroid hormones across all four matrices were the most pronounced changes observed. Resveratrol treatment reduced sulfated androgen precursors in blood, adipose tissue, and muscle tissue, and increased these metabolites in urine. Furthermore, markers of muscle turnover were increased and lipid metabolism was affected, with increased intracellular glycerol and accumulation of long-chain saturated, monounsaturated, and polyunsaturated (n3 and n6) free fatty acids in resveratrol-treated men. Finally, urinary derivatives of aromatic amino acids, which mainly reflect the composition of the gut microbiota, were altered upon resveratrol treatment. In conclusion, the non-targeted metabolomics approach applied to four different matrices provided evidence of subtle but robust effects on several metabolic pathways following resveratrol treatment for four months in men with metabolic syndrome—effects that, for the most part, would not have been detected by routine analyses. The affected pathways should be the focus of future clinical trials on resveratrol’s effects, and perhaps particularly the areas of steroid metabolism and the gut microbiome. MDPI 2017-03-04 /pmc/articles/PMC5372570/ /pubmed/28273841 http://dx.doi.org/10.3390/ijms18030554 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Korsholm, Anne Sofie Kjær, Thomas Nordstrøm Ornstrup, Marie Juul Pedersen, Steen Bønløkke Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment |
title | Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment |
title_full | Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment |
title_fullStr | Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment |
title_full_unstemmed | Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment |
title_short | Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ Treatment |
title_sort | comprehensive metabolomic analysis in blood, urine, fat, and muscle in men with metabolic syndrome: a randomized, placebo-controlled clinical trial on the effects of resveratrol after four months’ treatment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372570/ https://www.ncbi.nlm.nih.gov/pubmed/28273841 http://dx.doi.org/10.3390/ijms18030554 |
work_keys_str_mv | AT korsholmannesofie comprehensivemetabolomicanalysisinbloodurinefatandmuscleinmenwithmetabolicsyndromearandomizedplacebocontrolledclinicaltrialontheeffectsofresveratrolafterfourmonthstreatment AT kjærthomasnordstrøm comprehensivemetabolomicanalysisinbloodurinefatandmuscleinmenwithmetabolicsyndromearandomizedplacebocontrolledclinicaltrialontheeffectsofresveratrolafterfourmonthstreatment AT ornstrupmariejuul comprehensivemetabolomicanalysisinbloodurinefatandmuscleinmenwithmetabolicsyndromearandomizedplacebocontrolledclinicaltrialontheeffectsofresveratrolafterfourmonthstreatment AT pedersensteenbønløkke comprehensivemetabolomicanalysisinbloodurinefatandmuscleinmenwithmetabolicsyndromearandomizedplacebocontrolledclinicaltrialontheeffectsofresveratrolafterfourmonthstreatment |